Navigation Links
BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
Date:10/19/2010

scientific advisory board. He is an authority in ophthalmology and well-known for his seminal contributions in macular degeneration research. His lab made numerous foundational discoveries published in Nature, Nature Medicine, PNAS, and the Journal of Clinical Investigation; these include exceptional findings about the role of the innate immune system in the mechanisms and treatment of AMD. Dr. Ambati won the 2010 Cogan Award from The Association for Research in Vision and Ophthalmology (ARVO) for his contributions in macular degeneration research. "We are extremely honored that Dr. Ambati has agreed to join BMT as chair of our scientific advisory board," said BMT CEO, Sun Woo Hong. "He brings unparalleled expertise and experience in eye disease research, an area so fundamental to our success. We expect that the addition of his expertise will accelerate and strengthen our progress to develop RNAi therapeutics for AMD using our proprietary asiRNA platform."

Dr. Fruehauf has been appointed as the first external director to BMT's board. He is currently vice president of R&D at Aura Biosciences, and founder and president of ViThera Laboratories. Previously, he was a cofounder and VP of research at Cequent Pharmaceuticals, now Marina Biotech, where he oversaw the development from bench into clinical trials of the first oral RNAi therapeutic, CEQ508. Dr. Dong-ki Lee commented, "With Dr. Fruehauf joining our board, we are entering the next phase of BMT's growth. His expertise in building and managing early-stage biotech startup companies and achieving scientific progress towards key milestones is invaluable for our next steps: establishing business relationships and scientific alliances in the United States, and internationally."

The company is making its inaugural U.S. poster presentation at the 6th Annual Meeting of the Oligonucleotide Therapeutics Society, which begins tomorrow in Dana Point, California. The title i
'/>"/>

SOURCE BioMolecular Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ANGELES , June 2, 2015  CytRx Corporation ... company specializing in oncology, today announced that it has ... pending in the Delaware Court ... the Company,s current and former directors and officers, and ... The lawsuit, captioned In re CytRx Corp. Stockholder ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) has ... by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation ... Generator, ICE, X-ray)) & Indication (AF, VT, WPW) ... their offering. The global electrophysiology (EP) ... CAGR of 10.3% from 2014 to 2019 ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 /PRNewswire/ ... principal owner, Ampersand Capital Partners (Ampersand), announced the ... operation of Array BioPharma Inc. (Array).  Accuratus was ... Eagan, MN acquired Microtest ... GLP analytical and microbial testing services to the ...
Breaking Medicine Technology:CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
(Date:6/2/2015)... June 02, 2015 CRN International has been ... Platform to Employment , a Connecticut state program that takes ... and place them at appropriate companies. , Platform to Employment ... with the Connecticut Department of Labor. CRN, a 40-year-old radio ... the program, is being recognized for its “hard work and ...
(Date:6/2/2015)... COLUMBIA, Md. (PRWEB) June 02, 2015 ... of its LCMS-8060 triple quadrupole mass spectrometer. The ... series, the LCMS-8060 combines Shimadzu’s proprietary ultrafast technologies ... unparalleled combination results in outstanding data quality and ... and routine applications. , The LCMS-8060 features new ...
(Date:6/2/2015)... Zambia (PRWEB) June 02, 2015 ... businesses, today opened a new seed warehouse and office ... and meet farmer demand for both local and export ... , “Zambia could emerge as the breadbasket for ... said Worede Woldemariam, East and South Central Africa senior ...
(Date:6/2/2015)... 2015 PhishLine, LLC today announced ... Swenson Drive, Suite 125 in Waukesha, Wisconsin 53186. ... new base of operations for PhishLine’s current corporate ... growth. , Mark Chapman, Founder and President, commented ... as enterprise customers adopt our market leading service ...
(Date:6/2/2015)... a popular online store selling celebrity inspired fashion products, ... dresses. The company carries more than 1000 styles of ... a wide variety of summer events like wedding and ... quality trendy special occasion dresses and accessories. ... and cotton. Their products feature a wide range of ...
Breaking Medicine News(10 mins):Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2
... 2012 Testosterone, the primary male sex hormone, appears ... its effects have remained unclear. Nicole Carrier and Mohamed ... to elucidate these mechanisms. They,ve discovered that a ... in memory formation and regulation of stress responses, plays ...
... Society (ERS) and the European Centre for Disease Prevention ... Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards ... ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) ... in the EU/EEA in 2010 clearly showing that TB ...
... in men with prostate cancer before prostatectomy helped to reduce ... cancer, according to the results of a phase II study. ... at the Princess Margaret Hospital, University Health Network in Toronto, ... 2012, held here March 31 - April 4. Metformin ...
... FRIDAY, March 30 (HealthDay News) -- Cold conditions may affect ... research studies, a new study suggests. Researchers from the ... drugs tested on mice that were housed in chilly temperatures ... because being cold triggers changes in mice,s immune function and ...
... FRIDAY, March 30 (HealthDay News) -- While unseasonably warm weather ... thrilled with the early arrival of spring. Arriving along ... hay-fever sufferers sneezing at least a few weeks sooner than ... season starting early, but the pollen counts are breaking records. ...
... , FRIDAY, March 30 (HealthDay News) -- The declining ... a specialty is cause for concern because there,s already ... downward trend has occurred for the past six years, ... Medical schools need to provide more information and training ...
Cached Medicine News:Health News:Exploring the antidepressant effects of testosterone 2Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Metformin appeared to slow prostate cancer growth 2Health News:For Better Mouse Studies, Let Them Nest 2Health News:Warm Weather Triggers Early Allergy Season 2Health News:Warm Weather Triggers Early Allergy Season 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
Inquire...
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
100L...
Medicine Products: